Inhibition of carotis venous bypass graft disease by intraoperative nucleic acid-based therapy in rabbits

Thoracic and Cardiovascular Surgeon

Volumn 54, Issue 6, 2006, Pages 388-392

  Kusch, B ^a   Waldhans, S ^a   Sattler, A ^a   Wagner, A ^b   Hecker, M ^b   Moosdorf, R ^a   Vogt, Sebastian ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Animal model; Atherosclerosis; CABG; Gene therapy; Venous disease; Venous grafts

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; OLIGODEOXYNUCLEOTIDE; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL GRAFT; CAROTID ARTERY; CONSENSUS SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; DRUG MECHANISM; GRAFT OCCLUSION; IMMUNOHISTOCHEMISTRY; INTIMA; JUGULAR VEIN; MALE; MORPHOMETRICS; NONHUMAN; NONVIRAL GENE THERAPY; PEROPERATIVE CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; REVASCULARIZATION; TREATMENT OUTCOME;

ANIMALS; CAROTID ARTERIES; CORONARY ARTERY BYPASS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENDOTHELIN-1; GENE THERAPY; GRAFT OCCLUSION, VASCULAR; MALE; OLIGONUCLEOTIDES; RABBITS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TUNICA INTIMA;

EID: 33749474169     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924410     Document Type: Article

References (21)

1. Sabik III JF, Lytle BW, Blackstone EH et al. Comparison of saphenous vein and internal thoracic artery graft patency by coronary system. Ann Thorac Surg 2005; 79: 544-551
2. Lauth M, Cattaruzza M, Hecker M. ACE Inhibitor and AT1 antagonist blockade of deformation-induced gene expression in the rabbit jugular vein through B2 receptor activation. Arterioscler Thromb Vasc Biol 2001; 21: 61-66
3. Verma S, Badiwala MV, Weisel RD et al. C-reactive protein activates the nuclear factor κB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis. J Thorac Cardiovasc Surg 2003; 126: 1886-1891
4. Lauth M, Wagner AH, Cattaruzza M et al. Transcriptional control of deformation-induced preproendothelin-1 gene expression in endothelial cells. J Mol Med 2000; 78: 441-450
5. Lauth M, Berger MM, Cattaruzza M, Hecker M. Pressure-induced upregulation of preproendothelin-1 and endothelin B receptor expression in the rabbit jugular vein in situ: implication for vein graft failure? Arterioscler Throm Vasc Biol 2000; 20: 96-103
6. Buchwald AB, Wagner AH, Webel C, Hecker M. Decoy oligodesoxynucleotide against activator protein-1 reduces neointimal proliferation after coronary angioplasty in hypercholesterolemic minipigs. J Am Coll Cardiol 2002; 39: 732-738
7. Troitzsch D, Vogt S, Peukert A. Study of long-term anesthesia in rabbits. Tierarzt Prax 1996; 24: 519-521
8. Wülfing P, Diallo R, Kersting C et al. Expression of endothelin-1, endothelin-A, and endothelin-B Receptor in human breast cancer and correlation with long-term follow-up. Clin Canc Res 2003; 9: 4125-4131
9. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev 1995; 75: 519-560
10. Busse R, Fleming I. Pulsatile stretch and shear stress: physical stimuli determining the production of endothelium-derived relaxing factors. J Vasc Res 1998; 35: 73-84
11. Traub O, Berk BC. Laminar shear stress - mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 1998; 18: 677-685
12. Rössig L, Dimmeler S, Zeiher AM. Apoptosis in the vascular wall and atherosclerosis. Basic Res Cardiol 2001; 96: 11-22
13. Mann MJ, Whittemore AD, Donaldson MC et al. Ex vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet 1999; 354: 1493-1498
14. Alexander JH, Ferguson TB, Joseph DM et al. The project of ex vivo vein graft engineering via transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics. Am Heart J 2005; 150: 643-649
15. Shintani T, Sawa Y, Takahashi T et al. Intraoperative transfection of vein grafts with the NFκB decoy in a canine aortocoronary bypass model: a strategy to attenuate intimal hyperplasia. Ann Thorac Surg 2002; 74: 1132-1138
16. White SJ, Newby AC. Gene therapy for all aspects of vein-graft disease. J Card Surg 2002; 17: 549-555
17. O'Blenes SB, Zaidi SH, Cheah AY et al. Gene transfer of the serine elastase inhibitor elafin protects agianst vein graft degeneration. Circul 2000; 102 (Suppl III): III289-III295
18. Quax PH, Lamfers ML, Lardenoye JW et al. Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels. Circul 2000; 103: 562-569
19. Hirko MK, McShannic JR, Schmidt SP et al. Pharmacologic modulation of intimal hyperplasia in canine vein interposition grafts. J Vasc Surg 1993; 17: 877-887
20. Schödon B, Blau N, Schneemann M et al. Nitric oxide production depends on preceding tetrahydrobiopterin synthesis by endothelial cells: selective suppression of induced nitric oxide production by sepiapterin reductase inhibitors. Biochem Biophys Res Commun 1994; 199: 504-510
21. Welt FG, Woods TC, Edelman ER. Oral heparin prevents neointimal hyperplasia after arterial injury. Circul 2001; 104: 3121-3124